BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukemia
,
Stem cell
,
Avian flu virus
,
Quercetin
,
rs6983267
,
IL1A
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
comp protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Functional characterization of a rare pathogenic variant c.875G > A, p.(Cys292Tyr) in COMP.
Case Report: Whole-exome sequencing identified two novel COMP variants causing pseudoachondroplasia.
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in pa…
A case of localized tracheobronchial relapsing polychondritis with positive matrilin-1 staining.
Expression of cartilage oligomeric matrix protein (COMP) associates with capsular invasion in saliva…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Serum Cartilage Oligomeric Matrix Protein Levels After 12 Weeks of Different Exercises
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuv…
Dose-Response Relationship of Ambulatory Load and Cartilage - Pilot Study
Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA
To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suf…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ